Nanocapsules for the co-delivery of selol and doxorubicin to breast adenocarcinoma 4T1 cells in vitro.
Ganassin R, Merker C, Rodrigues MC, Guimarães NF, Sodré CSC, Ferreira QDS, da Silva SW, Ombredane AS, Joanitti GA, Py-Daniel KR, Zhang J, Jiang CS, de Morais PC, Mosiniewicz-Szablewska E, Suchocki P, Longo JPF, Meijer J, Estrela-Lopis I, de Azevedo RB, Muehlmann LA.
Ganassin R, et al. Among authors: ombredane as.
Artif Cells Nanomed Biotechnol. 2018 Dec;46(8):2002-2012. doi: 10.1080/21691401.2017.1408020. Epub 2017 Nov 27.
Artif Cells Nanomed Biotechnol. 2018.
PMID: 29179603
Free article.